Sequence Conversion Reaction Patent - Rosalind DX

EPO published patent EP4165184A2 titled 'Sequence Conversion Reaction' on March 25, 2026, assigned to Rosalind DX Pte. Ltd. The patent application covers molecular biology methods including C12Q classifications related to DNA/RNA analysis and amplification techniques. The application designates 39 European states including major markets DE, FR, GB, IT, and ES.

Patent applicants and competitors should review the published claims to assess IP strategy implications. Third parties have an opportunity to file observations during the opposition period. The patent covers IPC classifications C12Q 1/6816, C12Q 1/6858, C12Q 1/682, and related biotechnology methodology areas.